TABLE III.
Variable | Odds ratio (95% CI) | P-value |
---|---|---|
Prior ACS (increase of 1) | 0.8 (0.6–0.95) | <0.05 |
Home inhaler* | 6.0 (1.2–30) | <0.05 |
History of asthma* | 3.8 (0.9–15) | 0.06 |
RCSS (increase of 1) | 11 (2.1–53) | <0.005 |
SBP at ACS (increase of 10 mg of Hg) | 1.7 (0.99–2.8) | 0.06 |
DBP at 48 hr (increase of 10 mg of Hg) | 1.8 (1.2–2.8) | <0.01 |
Corticosteroid treatment | 20 (2.6–152) | <0.005 |
Transfusion | 0.03 (0.001–0.7) | <0.05 |
Hydroxyurea | 2.0 (0.4–10) | NS |
CI, confidence interval; ACS, acute chest syndrome; RCSS, respiratory clinical severity score; SBP, systolic blood pressure; Hg, mercury; DBP, diastolic blood pressure.
Either home inhaler or history of asthma was included in the multivariate model.